These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 18515410)

  • 1. Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer.
    Feldmann G; Habbe N; Dhara S; Bisht S; Alvarez H; Fendrich V; Beaty R; Mullendore M; Karikari C; Bardeesy N; Ouellette MM; Yu W; Maitra A
    Gut; 2008 Oct; 57(10):1420-30. PubMed ID: 18515410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers.
    Feldmann G; Dhara S; Fendrich V; Bedja D; Beaty R; Mullendore M; Karikari C; Alvarez H; Iacobuzio-Donahue C; Jimeno A; Gabrielson KL; Matsui W; Maitra A
    Cancer Res; 2007 Mar; 67(5):2187-96. PubMed ID: 17332349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of hedgehog signaling blockage and chemotherapy leads to tumor reduction in pancreatic adenocarcinomas.
    Bahra M; Kamphues C; Boas-Knoop S; Lippert S; Esendik U; Schüller U; Hartmann W; Waha A; Neuhaus P; Heppner F; Pietsch T; Koch A
    Pancreas; 2012 Mar; 41(2):222-9. PubMed ID: 22076568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer.
    Olive KP; Jacobetz MA; Davidson CJ; Gopinathan A; McIntyre D; Honess D; Madhu B; Goldgraben MA; Caldwell ME; Allard D; Frese KK; Denicola G; Feig C; Combs C; Winter SP; Ireland-Zecchini H; Reichelt S; Howat WJ; Chang A; Dhara M; Wang L; Rückert F; Grützmann R; Pilarsky C; Izeradjene K; Hingorani SR; Huang P; Davies SE; Plunkett W; Egorin M; Hruban RH; Whitebread N; McGovern K; Adams J; Iacobuzio-Donahue C; Griffiths J; Tuveson DA
    Science; 2009 Jun; 324(5933):1457-61. PubMed ID: 19460966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
    Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
    Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agents targeting the Hedgehog pathway for pancreatic cancer treatment.
    Bisht S; Brossart P; Maitra A; Feldmann G
    Curr Opin Investig Drugs; 2010 Dec; 11(12):1387-98. PubMed ID: 21154121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer.
    Feldmann G; Fendrich V; McGovern K; Bedja D; Bisht S; Alvarez H; Koorstra JB; Habbe N; Karikari C; Mullendore M; Gabrielson KL; Sharma R; Matsui W; Maitra A
    Mol Cancer Ther; 2008 Sep; 7(9):2725-35. PubMed ID: 18790753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chloroquine targets pancreatic cancer stem cells via inhibition of CXCR4 and hedgehog signaling.
    Balic A; Sørensen MD; Trabulo SM; Sainz B; Cioffi M; Vieira CR; Miranda-Lorenzo I; Hidalgo M; Kleeff J; Erkan M; Heeschen C
    Mol Cancer Ther; 2014 Jul; 13(7):1758-71. PubMed ID: 24785258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The inhibition of the Sonic Hedgehog (SHh) pathway improves the effects of chemotherapy in a model of ductal carcinoma of the pancreas in mice].
    Larsen CJ
    Bull Cancer; 2009 Sep; 96(9):829. PubMed ID: 19810163
    [No Abstract]   [Full Text] [Related]  

  • 10. Aspirin prolongs survival and reduces the number of Foxp3+ regulatory T cells in a genetically engineered mouse model of pancreatic cancer.
    Plassmeier L; Knoop R; Waldmann J; Kesselring R; Buchholz M; Fichtner-Feigl S; Bartsch DK; Fendrich V
    Langenbecks Arch Surg; 2013 Oct; 398(7):989-96. PubMed ID: 23989613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging monitors physiological changes with antihedgehog therapy in pancreatic adenocarcinoma xenograft model.
    Guimaraes AR; Rakhlin E; Weissleder R; Thayer SP
    Pancreas; 2008 Nov; 37(4):440-4. PubMed ID: 18953259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ciliogenesis and Hedgehog signalling are suppressed downstream of KRAS during acinar-ductal metaplasia in mouse.
    Bangs FK; Miller P; O'Neill E
    Dis Model Mech; 2020 Jul; 13(7):. PubMed ID: 32571902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal response to Hedgehog signaling restrains pancreatic cancer progression.
    Lee JJ; Perera RM; Wang H; Wu DC; Liu XS; Han S; Fitamant J; Jones PD; Ghanta KS; Kawano S; Nagle JM; Deshpande V; Boucher Y; Kato T; Chen JK; Willmann JK; Bardeesy N; Beachy PA
    Proc Natl Acad Sci U S A; 2014 Jul; 111(30):E3091-100. PubMed ID: 25024225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and pharmacologic abrogation of Snail1 inhibits acinar-to-ductal metaplasia in precursor lesions of pancreatic ductal adenocarcinoma and pancreatic injury.
    Fendrich V; Jendryschek F; Beeck S; Albers M; Lauth M; Esni F; Heeger K; Dengler J; Slater EP; Holler JPN; Baier A; Bartsch DK; Waldmann J
    Oncogene; 2018 Apr; 37(14):1845-1856. PubMed ID: 29367759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the Hedgehog pathway induces autophagy in pancreatic ductal adenocarcinoma cells.
    Xu Y; An Y; Wang X; Zha W; Li X
    Oncol Rep; 2014 Feb; 31(2):707-12. PubMed ID: 24297612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrations and therapeutics involving the developmental pathway Hedgehog in pancreatic cancer.
    Kelleher FC; McDermott R
    Vitam Horm; 2012; 88():355-78. PubMed ID: 22391312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of sonic hedgehog signal pathway enhances antiproliferative effect of EGFR inhibitor in pancreatic cancer cells.
    Hu WG; Liu T; Xiong JX; Wang CY
    Acta Pharmacol Sin; 2007 Aug; 28(8):1224-30. PubMed ID: 17640486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rottlerin suppresses growth of human pancreatic tumors in nude mice, and pancreatic cancer cells isolated from Kras(G12D) mice.
    Huang M; Tang SN; Upadhyay G; Marsh JL; Jackman CP; Srivastava RK; Shankar S
    Cancer Lett; 2014 Oct; 353(1):32-40. PubMed ID: 25050737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of hedgehog signaling pathway as a therapeutic strategy for pancreatic cancer.
    Xu FG; Ma QY; Wang Z
    Cancer Lett; 2009 Oct; 283(2):119-24. PubMed ID: 19232458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hedgehog inhibition with the orally bioavailable Smo antagonist LDE225 represses tumor growth and prolongs survival in a transgenic mouse model of islet cell neoplasms.
    Fendrich V; Wiese D; Waldmann J; Lauth M; Heverhagen AE; Rehm J; Bartsch DK
    Ann Surg; 2011 Nov; 254(5):818-23; discussion 823. PubMed ID: 22042473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.